Sickle Cell Anemia

The disease is most commonly seen in the black and brown population where the gene frequency for sickle hemoglobin (HbS) is 4%. As a result of newborn screening, immunizations, treatment of infections, disease modifying agents like hydroxyurea, and improved supportive care, the survivability has markedly improved over the last ten years. For more information, Visit the Massachusetts Hospital Sickle Cell Comprehensive Treatment Center.

The Division of Pediatric Hematology at Johns Hopkins Children’s Center cares for patients with diseases of the blood or blood-forming organs using the latest technologies and scientific discoveries, bolstered by a history of clinical excellence at Johns Hopkins. For more information, visit the Division of Pediatric Hematology at Johns Hopkins Children’s Center.